A novel bone-destructive pathway in periodontal disease
A novel bone-destructive pathway in periodontal disease
批准号:
8769678
负责人:
Joseph Holoshitz
金额:
$23.33万
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-07-01 至 2016-06-30
关键词:
AddressAllelesAmino Acid SequenceAntigensBiologyC57BL/6 MouseCellsChemicalsCodeComplementDiseaseDisease AssociationDisease modelEpitopesEventFutureGeneticHLA-DR AntigensHLA-DRB1HealthHumanImmune systemImmunohistochemistryIn VitroInflammatoryLigandsLigatureMediatingMedicalMolecularOsteoclastsPathogenesisPathway interactionsPeriodontal DiseasesPhysiologicalPorphyromonas gingivalisPositioning AttributePredispositionProcessPropertyPublic HealthResearchRheumatoid ArthritisSeveritiesSeverity of illnessSignal TransductionSpecificityT-LymphocyteTestingTransgenesTransgenic MiceTransgenic Organismsbasebonebone imagingin vivoinnovationinsightmalemimeticsmouse modelnovelnovel therapeuticsosteoclastogenesisserological markertool
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): We have recently demonstrated that the shared epitope (SE) contributes to rheumatoid arthritis (RA) pathogenesis by acting as a ligand that activates pro-osteoclastogenic signal transduction events. Given the association between RA and periodontal disease (PD), and the association of both conditions with HLA-DRB1 alleles that code the SE motif, here we will examine the hypothesis that this motif may directly contribute to bone damage severity in PD due to its signal transduction effects. The research plan has 2 specific aims: Specific Aim 1 will examine the effect of an exogenously added SE in a mouse model of PD, using a novel small SE-mimetic compound, cQKRAA which contains a common SE sequence motif. This SE-mimetic ligand has been recently shown to have potent pro-osteoclastogenic effects in vitro and in vivo. In Specific Aim 2 we will examine the effect of endogenous SE, using transgenic mice expressing HLA-DR molecules with the SE sequence, or control SE-negative sequence. In preliminary studies, the SE transgenic mice were found to have enhanced osteoclastogenic propensity. In both aims, the specificity of the SE effects on the severity of PD will be determined by inhibiting it with a novel specific SE-antagonistic compound. Thus, using novel research tools, the proposed studies will examine a new concept in the pathogenesis of PD. In the long run, the proposed research could provide a scientific basis for future studies to develop new therapeutic strategies for this common disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Gene-environment interaction pathways in rheumatoid arthritis
-
批准号:10600084
-
项目类别:
-
资助金额:$53.42万
-
财政年份:2019
-
负责人:Joseph Holoshitz
-
依托单位:
Gene-environment interaction pathways in rheumatoid arthritis
-
批准号:10380826
-
项目类别:
-
资助金额:$52.89万
-
财政年份:2019
-
负责人:Joseph Holoshitz
-
依托单位:
Gene-environment interaction pathways in rheumatoid arthritis
-
批准号:9912069
-
项目类别:
-
资助金额:$53.42万
-
财政年份:2019
-
负责人:Joseph Holoshitz
-
依托单位:
Empirical validation of a novel HLA-disease association theory in skin and rheumatic diseases
-
批准号:9464174
-
项目类别:
-
资助金额:$38.79万
-
财政年份:2017
-
负责人:Joseph Holoshitz
-
依托单位:
A novel mechanism of gene-environment interaction in autoimmune arthritis
-
批准号:8768943
-
项目类别:
-
资助金额:$23.32万
-
财政年份:2014
-
负责人:Joseph Holoshitz
-
依托单位:
A novel mechanism of gene-environment interaction in autoimmune arthritis
-
批准号:8898805
-
项目类别:
-
资助金额:$19.38万
-
财政年份:2014
-
负责人:Joseph Holoshitz
-
依托单位:
A Novel Immune Stimulatory Ligand in Autoimmunity-Associated Angiogenesis
-
批准号:8322049
-
项目类别:
-
资助金额:$34.99万
-
财政年份:2011
-
负责人:Joseph Holoshitz
-
依托单位:
A Novel Immune Stimulatory Ligand in Autoimmunity-Associated Angiogenesis
-
批准号:8506977
-
项目类别:
-
资助金额:$33.24万
-
财政年份:2011
-
负责人:Joseph Holoshitz
-
依托单位:
A Novel Immune Stimulatory Ligand in Autoimmunity-Associated Angiogenesis
-
批准号:8699012
-
项目类别:
-
资助金额:$34.29万
-
财政年份:2011
-
负责人:Joseph Holoshitz
-
依托单位:
A Novel Immune Stimulatory Ligand in Autoimmunity-Associated Angiogenesis
-
批准号:8581467
-
项目类别:
-
资助金额:$15.55万
-
财政年份:2011
-
负责人:Joseph Holoshitz
-
依托单位:
A Novel Immune Stimulatory Ligand in Autoimmunity-Associated Angiogenesis
-
批准号:8194448
-
项目类别:
-
资助金额:$34.99万
-
财政年份:2011
-
负责人:Joseph Holoshitz
-
依托单位:
Immune Modulating HLA-Coded Ligands in Rheumatoid Arthritis
-
批准号:9351478
-
项目类别:
-
资助金额:$38.75万
-
财政年份:2011
-
负责人:Joseph Holoshitz
-
依托单位:
Immune Modulating HLA-Coded Ligands in Rheumatoid Arthritis
-
批准号:9397628
-
项目类别:
-
资助金额:$4.65万
-
财政年份:2011
-
负责人:Joseph Holoshitz
-
依托单位:
Immune Modulating HLA-Coded Ligands in Rheumatoid Arthritis
-
批准号:9981415
-
项目类别:
-
资助金额:$38.75万
-
财政年份:2011
-
负责人:Joseph Holoshitz
-
依托单位:
MHC class II-Associated Endothelial Dysfunction
-
批准号:7739107
-
项目类别:
-
资助金额:$20.61万
-
财政年份:2009
-
负责人:Joseph Holoshitz
-
依托单位:
Class II MHC Allele-Specific Signaling: A New Paradigm in Disease Pathogenesis
-
批准号:8115930
-
项目类别:
-
资助金额:$30.18万
-
财政年份:2009
-
负责人:Joseph Holoshitz
-
依托单位:
MHC class II-Associated Endothelial Dysfunction
-
批准号:7936373
-
项目类别:
-
资助金额:$17.33万
-
财政年份:2009
-
负责人:Joseph Holoshitz
-
依托单位:
Class II MHC Allele-Specific Signaling: A New Paradigm in Disease Pathogenesis
-
批准号:7922654
-
项目类别:
-
资助金额:$30.48万
-
财政年份:2009
-
负责人:Joseph Holoshitz
-
依托单位:
Class II MHC Allele-Specific Signaling: A New Paradigm in Disease Pathogenesis
-
批准号:8307911
-
项目类别:
-
资助金额:$30.18万
-
财政年份:2009
-
负责人:Joseph Holoshitz
-
依托单位:
Immune dysregulation by the rheumatoid arthritis shared epitope
-
批准号:7644477
-
项目类别:
-
资助金额:$16.68万
-
财政年份:2008
-
负责人:Joseph Holoshitz
-
依托单位:
海外基金